(Q37929929)

25 August 2017

1 reference

title

Current concepts for a drug-induced inhibition of formation and action of thromboxane A2. (English)

1 reference

25 August 2017

H Patscheke

1

1 reference

25 August 2017

language of work or name

1 reference

1 May 1990

1 reference

25 August 2017

1 reference

25 August 2017

volume

60

1 reference

25 August 2017

issue

5

1 reference

25 August 2017

page(s)

261-268

1 reference

Ligand binding to thromboxane receptors on human platelets: correlation with biological activity

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF01736225

Inhibitory effect of a selective thromboxane A2 receptor antagonist, EP 092, on platelet aggregation in whole blood ex vivo and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01736225

AH23848: a thromboxane receptor-blocking drug that can clarify the pathophysiologic role of thromboxane A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01736225

Responsiveness of platelets and coronary arteries from different species to synthetic thromboxane and prostaglandin endoperoxide analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01736225

Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01736225

Prostanoid-induced contraction of human bronchial smooth muscle is mediated by TP-receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01736225

How is the level of free arachidonic acid controlled in mammalian cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01736225

Effect of treating ovariectomized guinea-pigs with estradiol and progesterone on basal and A23187-stimulated release of prostaglandins from the uterus superfused in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01736225

GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01736225

Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01736225

Preeclampsia: an imbalance in placental prostacyclin and thromboxane production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01736225

Increased Prostacyclin Biosynthesis in Patients with Severe Atherosclerosis and Platelet Activation

21 January 2018

1 reference

12 December 2020

Acetylsalicylic acid, bleeding time and age

1 reference

12 December 2020

Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets

1 reference

12 December 2020

Hydrogen peroxide and methyl mercury are primary stimuli of eicosanoid release in human platelets

1 reference

12 December 2020

Preeclampsia: a review of the role of prostaglandins

1 reference

12 December 2020

L-641,953 (R-8-fluoro-dibenzo[b, f]thiepin-3-carboxylic acid-5-oxide): a novel thromboxane-prostaglandin endoperoxide antagonist.

1 reference

12 December 2020

Differential Inhibition by Aspirin of Vascular and Platelet Prostaglandin Synthesis in Atherosclerotic Patients

1 reference

12 December 2020

Effects of ONO-3708, an antagonist of the thromboxane A2/prostaglandin endoperoxide receptor, on platelet aggregation and thrombosis

1 reference

12 December 2020

Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin

1 reference

12 December 2020

Increased thromboxane biosynthesis in normal pregnancy is mainly derived from platelets

1 reference

12 December 2020

Comparison of vascular and platelet thromboxane A2/prostaglandin H2 receptors in the pig

1 reference

12 December 2020

Characterization of the biosynthetic pathway of prostaglandin D2 in human platelet-rich plasma

1 reference

12 December 2020

Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects

1 reference

12 December 2020

Prostacyclin: its biosynthesis, actions, and clinical potential

1 reference

12 December 2020

Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man

1 reference

12 December 2020

Pharmacological actions of SQ 29,548, a novel selective thromboxane antagonist.

1 reference

12 December 2020

Evidence for homogeneity of thromboxane A2 receptor using structurally different antagonists

1 reference

12 December 2020

Acetylation of prostaglandin synthase by aspirin

1 reference

12 December 2020

R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--II. Pharmacological effects in vivo and ex vivo

1 reference

12 December 2020

Improvement of renal function with selective thromboxane antagonism in lupus nephritis

1 reference

12 December 2020

The affinities of prostaglandin H2 and thromboxane A2 for their receptor are similar in washed human platelets

1 reference

12 December 2020

Metabolism of thromboxane B2 in man. Identification of twenty urinary metabolites

1 reference

12 December 2020

11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation

1 reference

12 December 2020

Differential inhibition of prostacyclin production and platelet aggregation by aspirin

1 reference

12 December 2020

Effect of alternate-day regular and enteric-coated aspirin on platelet aggregation, bleeding time, and thromboxane A2 levels in bleeding-time blood

1 reference

12 December 2020

Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2.

1 reference

12 December 2020

Thromboxane synthase inhibition potentiates washed platelet activation by endogenous and exogenous arachidonic acid

1 reference

12 December 2020

The clinical significance of inhibition of renal prostaglandin synthesis

1 reference

12 December 2020

Effects of a selective inhibitor of thromboxane synthetase on human blood platelet behaviour.

1 reference

12 December 2020

Different pharmacologic activities for 13-azapinane thromboxane A2 analogs in platelets and blood vessels

1 reference

12 December 2020

Effects of low doses of aspirin, 10 mg and 30 mg daily, on bleeding time, thromboxane production and 6-keto-PGF1 alpha excretion in healthy subjects

1 reference

12 December 2020

Administration to man of UK-37,248-01, a selective inhibitor of thromboxane synthetase

1 reference

12 December 2020

Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides

1 reference

12 December 2020

(5Z)-7-(2,2-Dimethyl-4-phenyl-1,3-dioxan-cis-5-yl)heptenoi c acid: a specific thromboxane A2 receptor antagonist

1 reference

12 December 2020

Stimulation of human platelet adenylate cyclase by prostaglandin D2

1 reference

12 December 2020

Synthesis and structure of the platelet aggregation factor thromboxane A2

1 reference

12 December 2020

Pharmacology of L-655,240 (3-[1-(4-chlorobenzyl)-5-fluoro-3-methyl-indol-2-yl]2,2-dimethylpro pan oic acid); a potent, selective thromboxane/prostaglandin endoperoxide antagonist

1 reference

12 December 2020

Further studies on the effects of epimers of thromboxane A2 antagonists on platelets and veins

1 reference

12 December 2020

The pharmacokinetic and pharmacodynamic profiles of the thromboxane A-2 receptor blocker BM 13.177

1 reference

12 December 2020

Antagonism of U46619-induced aggregation of human and canine platelets by four TXA2 receptor antagonists

1 reference

12 December 2020

A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2

1 reference

12 December 2020

Urine i-TXB2 in renal allograft rejection

1 reference

12 December 2020

Redirection of prostaglandin endoperoxide metabolism at the platelet-vascular interface in man

1 reference

12 December 2020

BM 13.177, A SELECTIVE BLOCKER OF PLATELET AND VESSEL WALL THROMBOXANE RECEPTORS, IS ACTIVE IN MAN

1 reference

12 December 2020

Aspirin selectively inhibits prostaglandin production in human platelets

1 reference

12 December 2020

Irreversible inhibition of the TXA2/PGH2 receptor of human platelets by a photoaffinity ligand

1 reference

12 December 2020

Monitoring the entry of new platelets into the circulation after ingestion of aspirin

1 reference

12 December 2020

Modulation of human platelet adenylate cyclase by prostacyclin (PGX)

1 reference

12 December 2020

Arachidonic acid metabolism by human monocytes. Studies with platelet-depleted cultures

1 reference

12 December 2020

Urinary thromboxane B2 and prostaglandin E2 in the hepatorenal syndrome: evidence for increased vasoconstrictor and decreased vasodilator factors

1 reference

12 December 2020

Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease

1 reference

12 December 2020

Improved aortocoronary bypass patency by low-dose aspirin (100 mg daily). Effects on platelet aggregation and thromboxane formation

1 reference

12 December 2020

Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets

1 reference

12 December 2020

Inhibition of prostacyclin and thromboxane A2 generation by low-dose aspirin at the site of plug formation in man in vivo

1 reference

12 December 2020

Endogenous prostacyclin biosynthesis and platelet function during selective inhibition of thromboxane synthase in man.

1 reference

12 December 2020

Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2

1 reference

12 December 2020

Difluorothromboxane A2 and stereoisomers: stable derivatives of thromboxane A2 with differential effects on platelets and blood vessels

1 reference

12 December 2020

13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor

1 reference

12 December 2020

Eicosenoid biosynthesis and platelet function with advancing age.

1 reference

12 December 2020

The inhibitory effect of GR32191, a thromboxane receptor blocking drug, on human platelet aggregation, adhesion and secretion

1 reference

12 December 2020

Platelet activation in unstable coronary disease

1 reference

12 December 2020

Thromboxanes: selective biosynthesis and distinct biological properties

1 reference

12 December 2020

Characterization of contractile prostanoid receptors on human airway smooth muscle

1 reference

12 December 2020

Evidence that prostaglandin endoperoxides can induce platelet aggregation in the absence of thromboxane A2 production

1 reference

12 December 2020

Synthesis and biological properties of a 9,11-azo-prostanoid: highly active biochemical mimic of prostaglandin endoperoxides

1 reference

12 December 2020

Aspirin and other platelet active drugs. Relationship among dose, effectiveness, and side effects

1 reference

12 December 2020

Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors

1 reference

12 December 2020

Prevention of pre-eclampsia by early antiplatelet therapy

1 reference

12 December 2020

9,11-epoxyiminoprosta-5,13-dienoic acid is a thromboxane A2 antagonist in human platelets

1 reference

12 December 2020

1 reference

12 December 2020

Desensitization of platelet thromboxane A2/prostaglandin H2 receptors by the mimetic U46619

1 reference

12 December 2020

Transient concentrations and agonist potency of PGH2 in platelet activation by endogenous arachidonate

1 reference

12 December 2020

Possible significance of small numbers of functional platelets in a population of aspirin-treated platelets in vitro and in vivo

1 reference

12 December 2020

Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs

1 reference

12 December 2020

Studies on the characterisation of prostanoid receptors: a proposed classification

1 reference

12 December 2020

Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides

1 reference

12 December 2020

Characterization of platelet thromboxane A2/prostaglandin H2 receptor by a novel thromboxane receptor antagonist, [3H]S-145

1 reference

12 December 2020

Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus

1 reference

12 December 2020

Role of proaggregatory and antiaggregatory prostaglandins in hemostasis. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism

1 reference

12 December 2020

The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies

1 reference

12 December 2020

Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction

1 reference

12 December 2020

Serum albumin enhances the impairment of platelet aggregation with thromboxane synthase inhibition by increasing the formation of prostaglandin D2.

1 reference

12 December 2020

Biosynthesis of thromboxane B2 and 12-L-hydroxy-5,8,10-heptadecatrienoic acid in human platelets. Evidence for a common enzymatic pathway

1 reference

12 December 2020

Prostaglandin F2α antagonizes thromboxane A2-induced human platelet aggregation

1 reference

12 December 2020

The pharmacological profile of the thromboxane A2 antagonist BM 13.177. A new anti-platelet and anti-thrombotic drug

1 reference

12 December 2020

Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae

1 reference

12 December 2020

Effects of low-dose aspirin on endogenous eicosanoid formation in normal and atherosclerotic men

1 reference

12 December 2020

RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2

1 reference

12 December 2020

Increased urinary excretion of thromboxane B2 and 2,3-dinor-TxB2 in cyclosporin A nephrotoxicity

1 reference

12 December 2020

Platelet function and biosynthesis of prostacyclin and thromboxane A2 in whole blood after aspirin administration in human subjects.

1 reference

12 December 2020

Biochemical evidence of platelet activation in patients with persistent unstable angina

1 reference

12 December 2020

In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis

1 reference

12 December 2020

Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. Comparison of platelets from responders and nonresponders

1 reference

12 December 2020

Thromboxane release during percutaneous transluminal coronary angioplasty

1 reference

12 December 2020

Isolation and Structure of Two Prostaglandin Endoperoxides That Cause Platelet Aggregation

1 reference

12 December 2020

Estimated rate of thromboxane secretion into the circulation of normal humans

1 reference

12 December 2020

Pharmacologic inhibition of thromboxane synthetase and platelet aggregation: modulatory role of cyclooxygenase products

1 reference

12 December 2020

Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin

1 reference

12 December 2020

Effects of thromboxane antagonist EP 045 on platelet aggregation

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01736225

1 reference

25 August 2017

1 reference